Hyperlipidaemia | Human Biospecimens Online

Hyperlipidaemia

Use the menu on the left side to filter for your ideal biospecimen

Hyperlipidemia, also known as dyslipidemia, is a chronic medical condition characterized by high cholesterol levels or fats in the blood. An increase in the amount of high-density lipoproteins (HDL cholesterol), low-density lipoproteins (LDL), and triglycerides in the blood lead to fat deposition in the arteries resulting in atherosclerosis and artery blockage.

Show rows
|< < of > >|

Hyperlipidemia is an adult-onset illness that can be inherited or acquired due to underlying conditions like obesity, unhealthy lifestyle, high cholesterol diet, and diabetes mellitus. It is one of the major risk factors for developing cardiovascular diseases

Symptoms of high cholesterol levels (Hyperlipidemia)

Often Hyperlipidemia patients are asymptomatic and remain undiagnosed for a long time. As cholesterol and triglyceride levels in the blood rise, narrowing of arteries occur due to fat deposition and result in hypertension and other cardiovascular complications. Symptomatic patients experience shortness of breath, palpitation, chest pain, difficulty in movement, sweating, anxiety, high BP and increased BMI based on the severity of the illness. However, early diagnosis, timely initiation of treatment with adequate control of cholesterol can prevent complications.

Ongoing Research on Hyperlipidemia (High Cholesterol Levels)

Ongoing research is focused on understanding its role in cardiovascular diseases, metabolic disorders, and other health complications. Studies are examining how elevated levels of LDL cholesterol and triglycerides contribute to the buildup of arterial plaques, leading to conditions such as atherosclerosis, heart attacks, and strokes. Researchers are also exploring the genetic factors behind cholesterol metabolism and the effectiveness of new therapies, including PCSK9 inhibitors, statins, and lifestyle interventions. Additionally, innovative biomarkers and imaging technologies are being developed to improve early diagnosis and predict patient outcomes more accurately. This research is pivotal in finding better strategies for managing hyperlipidemia, preventing its complications, and reducing the global burden of cardiovascular diseases.

An Insight into High cholesterol Biospecimens/ Hyperlipidemia Samples We Offer:

Thinking forward to the biospecimen revolution, Central BioHub connects certified global biospecimen suppliers to life science researchers worldwide. With the efforts to streamline the tedious biospecimen procurement process, our most extensive clinical network caters to researchers' biosample demands, enabling them to procure high cholesterol samples through our online marketplace.

Expediting research, Central BioHub brings you a wide array of research samples from patients with symptoms of high cholesterol.We provide human Lipid samples such as  human serum and plasma samples assiduously screened for HDL (good cholesterol), LDL and triglycerides to confirm the illness. All biological specimens are well annotated with detailed clinical information and well preserved cryogenically at <-18 °C at our supplier's biorepository. Central BioHub ensures safe, cost-effective and fastest delivery of research samples to your laboratory. Have a hassle-free human biospecimen procurement with expert assistance from Central BioHub. Contact us for more information on available hyperlipaemia samples for research.

Explore advanced search options to order hyperlipidemia biospecimens by clicking Clinical Diagnosis, ICD-10-CM codes, Matrix, and Laboratory Parameters.

Hyperlipidemia, also known as dyslipidemia, is a chronic medical condition characterized by a greater amount of lipids or fats in the blood. An increase in the number of high-density lipoproteins (HDL), low-density lipoproteins (LDL), and triglycerides in the blood lead to fat deposition in the arteries resulting in atherosclerosis and artery blockage. Hyperlipidemia is an adult-onset illness that can be inherited or acquired due to underlying conditions like obesity, unhealthy lifestyle, and diabetes mellitus. It is one of the main risk factors for developing cardiovascular diseases.
Hyperlipidaemia normally does not manifest symptoms until it has progressed to the point where patients are experiencing life-threatening problems, such as a heart attack or stroke. These can happen when excessive cholesterol causes plaque to build up in the arteries, restricting or blocking blood flow. Only blood monitoring will reveal blood cholesterol levels.
Untreated hyperlipidemia can lead to the deposition of plaques to the blood vessels called atherosclerosis, which can lead to severe complications such as heart attack, stroke, coronary heart disease, cardiac arrest, peripheral artery diseases, and macrovascular diseases.
Central BioHub, the leading human biospecimen marketplace, offers high-quality human serum and plasma samples for cardiovascular research. All biospecimens originate from consented and diagnosed donors and are stored at = -18°C in our biobank.